These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 9240645

  • 1. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
    Calais G, Dorval E, Louisot P, Bourlier P, Klein V, Chapet S, Reynaud-Bougnoux A, Huten N, De Calan L, Aget H, Le Floch O.
    Int J Radiat Oncol Biol Phys; 1997 Jul 01; 38(4):769-75. PubMed ID: 9240645
    [Abstract] [Full Text] [Related]

  • 2. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE, Qian C, Kocha WI, Coia LR, Herskovic A, Graham M.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):593-9. PubMed ID: 9112458
    [Abstract] [Full Text] [Related]

  • 3. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
    Yorozu A, Dokiya T, Oki Y.
    Int J Radiat Oncol Biol Phys; 1999 Sep 01; 45(2):271-5. PubMed ID: 10487545
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H.
    Int J Radiat Oncol Biol Phys; 1998 Mar 15; 40(5):1049-59. PubMed ID: 9539559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
    Brunner TB, Rupp A, Melzner W, Grabenbauer GG, Sauer R.
    Strahlenther Onkol; 2008 Jan 15; 184(1):15-22. PubMed ID: 18188518
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ.
    Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):817-22. PubMed ID: 9652843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemoradiotherapy of esophageal carcinoma.
    Poplin EA, Khanuja PS, Kraut MJ, Herskovic AM, Lattin PB, Cummings G, Gaspar LE, Kinzie JL, Steiger Z, Vaitkevicius VK.
    Cancer; 1994 Aug 15; 74(4):1217-24. PubMed ID: 8055441
    [Abstract] [Full Text] [Related]

  • 14. [The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study].
    Sola B, Airoldi M, Orecchia R, Rovea P, Fracchia F, Boidi Trotti A, Tessa M, Foco A, Oliaro A, Casadio C, Dei Poli M.
    Radiol Med; 1996 Apr 15; 91(4):456-9. PubMed ID: 8643859
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.
    Damle S, Beitler JJ, Haynes H, Camacho M, Wolf E, Wadler S.
    Am J Clin Oncol; 1999 Aug 15; 22(4):391-5. PubMed ID: 10440197
    [Abstract] [Full Text] [Related]

  • 18. [Chemotherapy with cisplatinum, carboplatin and 5FU-folinic acid, followed by concomitant chemo-radiotherapy in unresectable esophageal carcinomas].
    Hennequin C, Salemkour A, Mal F, Lecomte T, Boudet MJ, Perniceni T, Gayet B, Maylin C, Raymond E.
    Bull Cancer; 2001 Feb 15; 88(2):203-7. PubMed ID: 11257595
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 15; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 20. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.